Biocytogen Establishes Two Business Divisions To Distinguish Preclinical Models and Services (BioMice) from Antibody Drug R&D
BEIJING--(BUSINESS WIRE)--Aug 30, 2023--
Stay updated with breaking news from Embryonic Stem Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BEIJING--(BUSINESS WIRE)--Aug 30, 2023--
Biocytogen Pharmaceuticals Co., Ltd. announced the official formation of two major business divisions to represent the company?s product, service, and asset portfolio. Over the last decade,...
Researchers in China implanted the structures in three surrogate monkeys, but they did not become viable fetuses.
Dublin, Dec. 21, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Therapy Market by Cell Source (Adipose Tissue-Derived Mesenchymal Stem Cells, Bone...
/PRNewswire/ -- NewStem Ltd., a bio-platform company, today announced a collaboration with the MSK Innovation Hub to further optimize and validate NewStem's...